Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

crowd photo

The NIHR Oxford Biomedical Research Centre (BRC) has received more than €270,000 from the European Commission as a part of a multi-nation research project to promote citizen science.

Oxford’s involvement will entail the BRC and the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) carrying our research into the role of steroid hormones in the treatment of non-alcoholic fatty liver disease (NAFLD), obesity and type 2 diabetes.

This would be a first study undertaken with a citizen science approach in the domain of Diabetes, Endocrinology and Metabolism in general and NAFLD in particular.

The Oxford researchers include OCDEM researcher and BRC Theme Lead for Diabetes and Metabolism, Prof Jeremy Tomlinson, as well as the BRC’s Chief Operating Officer, Dr Vasiliki Kiparoglou and BRC researcher Dr Syed Ghulam Sarwar Shah.

Prof Tomlinson explained: “We are aiming to use this citizen science approach to develop a better understanding of the diurnal variation, along with circadian rhythm, of hepatic lipid metabolism in overweight patients in different types of conditions, before and after a lifestyle intervention a weight loss programme.

“For the first time, we will be able to integrate data collected in this area with other qualitative information related to daily life, wellbeing and lifestyles of the participants, allowing us to compare biomedical measurements with the patients’ daily experiences.”

The information gathered in this project will be incorporated into a wider research programme on “Metabolism and Steroid Hormone Biology” and will contribute to the development of new screening tools and novel interventions with the ultimate aim of improving patient care.

Read more about the project on the BRC website

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Enterprise Associate Interview with Dr Shilpa Nagarajan

Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Fundraising for award in memory of Dr Ling Felce

The Ling Felce award will promote cross-disciplinary excellence in bioinformatics.